|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/28 | |
| A61K 39/395 | |||
| A61P 35/00 | |||
| C07K 14/705 | |||
| C07K 14/71 | |||
| C07K 16/40 |
| (11) | Patento numeris | 2744827 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12753873.4 |
| Europos patento paraiškos padavimo data | 2012-08-16 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-06-25 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-10-03 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2012/051038 |
| Data | 2012-08-16 |
| (87) | Numeris | WO 2013/028442 |
| Data | 2013-02-28 |
| (30) | Numeris | Data | Šalis |
| 201161525308 P | 2011-08-19 | US | |
| 201261587213 P | 2012-01-17 | US | |
| 201261674405 P | 2012-07-23 | US |
| (72) |
THURSTON, Gavin, US
|
| (73) |
Regeneron Pharmaceuticals, Inc.,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (54) | ANTI-TIE2 ANTIBODIES USES THEREOF |
| ANTI-TIE2 ANTIBODIES USES THEREOF |